Ameri100 Enters Greenfield Healthcare Sector With New Win With MedData

ATLANTA, July 17, 2018 (GLOBE NEWSWIRE) -- AMERI Holdings, Inc. (Nasdaq:AMRH) (“Ameri100”), a specialized SAP® cloud, digital, and enterprise services company, today announced that it has secured a project to implement a robotic process automation solution with MedData, a leading provider of patient-facing financial services for hospitals and health systems. The new win, the first for Ameri100 in the healthcare sector, will center on the implementation of UiPath’s Robotic Process Automation (RPA) solution as a first step in the modernization and optimization of MedData’s IT legacy platform, and positions Ameri100 as a key strategic partner in driving MedData’s digital transformation.

RPA will enable MedData to transform and improve internal processes to create better customer experiences. Ameri100 will also help automate back-end processing that, when combined with RPA and business process management, will help MedData to gain cost, performance and quality benefits by automating high-volume, complex yet routine business processes. In support of the implementation of RPA, Ameri100 will establish an RPA Center of Excellence at MedData to embed RPA deeply across the client and to redistribute accumulated knowledge and resources for future deployments.

“The healthcare sector represents a significant, long-term opportunity for Ameri100 as enterprises move to prioritize patient experiences through the deployment of new technologies that improve not only patient satisfaction levels, but also enterprises’ bottom lines. Adding disruptive technologies and services, such as RPA, artificial intelligence/machine learning and blockchain, to our service offerings portfolio enhances our digital transformation services and helps clients unlock the full value of their investments in IT,” said Brent Kelton, CEO of Ameri100.  “With a proven reputation for developing and implementing successful digital transformation migration paths across other business verticals, we are proactively positioning ourselves in front of healthcare enterprises just starting on their journeys.”

Sue Chilson, Chief Information Officer of MedData, stated, “Today’s automation projects are very different from the IT projects of the past. They are largely business-led and have very short cycles for deployment, thereby helping companies realize value much quicker. This allows us to be much more innovative. While transactional automation is one of the key focuses, we intend to shrink the time it takes to respond to and solve issues that arise, improve quality, and reduce risk. This area is maturing rapidly and playing a greater role in making companies faster, smarter, and more agile.”

About Ameri100

Ameri100 is a specialized SAP® cloud, digital and enterprise services company which provides SAP® services to customers worldwide. Headquartered in Suwanee, Georgia, Ameri100 has offices in the U.S. and Canada. The Company also has global delivery centers in India. With its bespoke engagement model, the Company delivers transformational value to its clients across industry verticals. For further information, visit

About MedData

MedData, a MEDNAX (NYSE:MD) company, is a leading provider of technology-enabled management services for hospitals and health systems that serve the entire patient financial lifecycle from pre-visit through post-discharge while improving the patient experience and helping them engage better with their providers. For four decades, the company has been providing innovative solutions to the medical community and serving hundreds of millions of patients across numerous medical specialties. MedData currently serves more than 10,000 physicians at a growing network of 3,000+ facilities nationwide from its headquarters in Brecksville, Ohio, and more than 20 regional offices across the U.S. To learn more about MedData’s patient-focused solutions platform, please visit the MedData website.

Forward-Looking Statements

This press release includes forward-looking statements that relate to the business and expected future events or future performance of Ameri100 and involve known and unknown risks, uncertainties and other factors that may cause its actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Words such as, but not limited to, "believe," "expect," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "could," and similar expressions or phrases identify forward-looking statements. Forward-looking statements include, but are not limited to, statements about Ameri100's financial and growth projections as well as statements concerning our plans, predictions, estimates, strategies, intentions, beliefs and other information concerning our business and the markets in which we operate. The future performance of Ameri100 may be adversely affected by the following risks and uncertainties: the level of market demand for our services, the highly-competitive market for the types of services that we offer, market conditions that could cause our customers to reduce their spending for our services, our ability to create, acquire and build new businesses and to grow our existing businesses, our ability to attract and retain qualified personnel, currency fluctuations and market conditions around the world, and other risks not specifically mentioned herein but those that are common to industry. For a more detailed discussion of these factors and risks, investors should review Ameri100's reports on Form 10-K and other reports filed with the Securities and Exchange Commission (the “SEC”), which can be accessed through the SEC's website. Forward-looking statements in this press release are based on management's beliefs and opinions at the time the statements are made. All forward-looking statements are qualified in their entirety by this cautionary statement, and Ameri100 undertakes no duty to update this information to reflect future events, information or circumstances.

Corporate Contact:
Viraj Patel, Chief Financial Officer

Investor Relations Contact:
Jody Burfening/Sanjay M. Hurry
LHA Investor Relations
(212) 838-3777